March 9 (Reuters) - The U.S. health regulator issued a draft guidance on Monday to help drugmakers develop cheaper versions ...

The Trump administration launched a drug pricing initiative offering immediate savings, but experts debated whether lower ...

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.

Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?

Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.

As President Donald Trump rolls out his TrumpRx proposal to cut prescription drug prices, economists are raising questions about what happens when prices are capped and whether short-term savings for ...

Medicare open enrollment, which lasts until Dec. 7, provides beneficiaries the opportunity to evaluate their health care spending, including prescription costs, for 2026. Certain changes, including a ...

Medicare costs could decrease under a new proposal from the Trump administration that would shift the drug payment model entirely. The Centers for Medicare & Medicaid Services (CMS) released details ...